https://www.marketscreener.com/quote/stock/LYSOGENE-33951021/news/Lysogene-announces-important-updates-on-AAVance-phase-2-3-clinical-trial-with-LYS-SAF302-in-MPS-II-30726217/?utm_source=telegram&utm_medium=social&utm_campaign=share